Perspective Therapeutics (CATX) News Today → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free CATX Stock Alerts 1.66 +0.02 (+0.91%) (As of 12:34 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePerspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETsglobenewswire.com - April 30 at 7:00 AMPerspective Therapeutics (NYSEAMERICAN:CATX) Stock Price Up 6.6%marketbeat.com - April 29 at 5:29 PMPerspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Sees Significant Growth in Short Interestamericanbankingnews.com - April 28 at 2:14 AMPerspective Therapeutics (NYSEAMERICAN:CATX) Hits New 1-Year High at $1.62americanbankingnews.com - April 25 at 5:44 AMPerspective Therapeutics (NYSEAMERICAN:CATX) Hits New 12-Month High at $1.62marketbeat.com - April 23 at 12:09 PMPerspective Therapeutics (NYSEAMERICAN:CATX) Trading Down 7.2%marketbeat.com - April 16 at 3:44 PMPerspective Therapeutics (NYSEAMERICAN:CATX) Trading Up 3.7%marketbeat.com - April 15 at 5:31 PMQ1 2024 EPS Estimates for Perspective Therapeutics, Inc. Raised by B. Riley (NYSEAMERICAN:CATX)marketbeat.com - April 12 at 6:09 AMPerspective Therapeutics (NYSEAMERICAN:CATX) Sees Unusually-High Trading Volumemarketbeat.com - April 11 at 12:46 PMPerspective Therapeutics (NYSEAMERICAN:CATX) Price Target Raised to $1.70marketbeat.com - April 9 at 2:17 PMPerspective Therapeutics to Participate at Upcoming April Investor Conferencesglobenewswire.com - April 8 at 8:00 AMPerspective Therapeutics (NYSEAMERICAN:CATX) Sets New 12-Month High at $1.60marketbeat.com - April 6 at 7:06 AMPerkins Capital Management Inc. Lowers Holdings in Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX)marketbeat.com - April 1 at 11:45 AMPerspective Therapeutics' (CATX) Outperform Rating Reiterated at Oppenheimermarketbeat.com - April 1 at 10:22 AMPerspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Resultsglobenewswire.com - March 28 at 7:30 AMBuy Rating Affirmed for Perspective Therapeutics Amid Clinical Success and Strategic Partnershipsmarkets.businessinsider.com - March 21 at 4:07 PMPerspective Therapeutics Inc.wsj.com - March 19 at 11:14 PMOppenheimer Reaffirms "Outperform" Rating for Perspective Therapeutics (NYSEAMERICAN:CATX)marketbeat.com - March 19 at 9:33 AMPerspective Therapeutics partners with Bristol Myers for its metastatic melanoma treatment studymsn.com - March 18 at 12:04 PMPerspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanomafinance.yahoo.com - March 18 at 12:04 PMenGene Holdings GAAP EPS of -$0.46msn.com - March 12 at 8:41 AMPerspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024finance.yahoo.com - March 11 at 10:41 AMInsider Buying: Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Major Shareholder Acquires 60,431,039 Shares of Stockinsidertrades.com - March 11 at 5:18 AMPerspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Major Shareholder Acquires 57,409,487.05 in Stockmarketbeat.com - March 8 at 1:32 PMPerspective Therapeutics raises $87 million on heels of big January roundbizjournals.com - March 7 at 6:32 AMHighTower Advisors LLC Purchases Shares of 1,147,038 Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX)marketbeat.com - March 5 at 4:37 AMPerspective Therapeutics Announces $87.4 Million Private Placementglobenewswire.com - March 4 at 9:45 AMPerspective Therapeutics to Participate at Upcoming Investor Conferencesfinance.yahoo.com - February 26 at 12:35 PMPTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growthfinance.yahoo.com - February 13 at 1:34 PMPerspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 12 at 12:33 PMPerspective Therapeutics Updates Corporate Presentation Onlinemsn.com - February 6 at 10:24 AMPerspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platformfinance.yahoo.com - February 1 at 8:39 AMHeybike Will Soon Release Hero -- A Powerful All-Terrain E-bikefinance.yahoo.com - February 1 at 3:39 AMPerspective Therapeutics And 3 Other Stocks Under $2 Insiders Are Buyingmsn.com - January 29 at 5:13 PMPerspective gains as B. Riley sees over 100% upside on radiopharma prospectsmsn.com - January 26 at 8:53 PMRobert F. Williamson III Purchases 22,134 Shares of Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Stockmarketbeat.com - January 26 at 7:02 PMPerspective Therapeutics (NYSEAMERICAN:CATX) Now Covered by Analysts at B. Rileymarketbeat.com - January 26 at 12:44 PMCancer treatment company Perspective Therapeutics raises $90Mbizjournals.com - January 24 at 1:44 AMPerspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placementfinance.yahoo.com - January 22 at 7:10 PMWhy Perspective Therapeutics (CATX) Shares Are Fallingmsn.com - January 18 at 1:28 PMPerkins Capital Management Inc. Invests $731,000 in Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX)marketbeat.com - January 18 at 12:42 PMPerspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placementfinance.yahoo.com - January 18 at 7:43 AMPerspective Therapeutics Announces Proposed Public Offeringfinance.yahoo.com - January 17 at 4:41 PMPerspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01finance.yahoo.com - January 17 at 8:41 AMShort Interest in Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Expands By 6.6%marketbeat.com - January 15 at 5:48 PMPerspective Therapeutics Gets Equity Investment, Strategic Agreements With Lantheusmarketwatch.com - January 9 at 11:14 AMPerspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capabilityfinance.yahoo.com - January 9 at 11:14 AMPerspective Enters Patent License Agreement For PSMA Alpha-PET DoubLET Platform Technologymarkets.businessinsider.com - January 5 at 11:34 AMPerspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer Treatmentfinance.yahoo.com - January 5 at 11:34 AMPerspective Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 2 at 10:15 AM Get Perspective Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CATX and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon’s New A.I. Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. CATX Media Mentions By Week CATX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CATX News Sentiment▼0.240.34▲Average Medical News Sentiment CATX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CATX Articles This Week▼51▲CATX Articles Average Week Get Perspective Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CATX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MDXG News Today AORT News Today ATRC News Today FNA News Today SILK News Today ATRI News Today KIDS News Today TMCI News Today EMBC News Today SIBN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:CATX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
